Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts

About this trial

This study explores whether adding early nurse-led and psychological support after the diagnosis of retinitis pigmentosa (RP) can improve patient experience and emotional well-being. RP is a rare, progressive eye disease often diagnosed after a long and difficult process, and receiving the diagnosis can be emotionally distressing.

Eighty newly diagnosed adults will be randomly assigned to either usual care or an enhanced pathway that includes early follow-up with a nurse, structured emotional monitoring, and a psychologist visit at six months.

The study aims to determine if this structured support improves patient satisfaction and reduces anxiety and depression compared with standard care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with retinitis pigmentosa (RP) and followed at the Quinze-Vingts Rare Eye Disease Center, with diagnosis made after the project begins

Aged 18 to 65 years

Male or female

French-speaking

Disqualifiers

Pregnant women

Participants enrolled in a therapeutic clinical trial within the past 12 months

Individuals deprived of liberty by judicial or administrative decision

Adults under legal protection or unable to provide informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Enhanced post-diagnostic support

    Behavioral

    Nurse-led and psychologist consultation

  • Usual Care

    Behavioral

    Standard ophthalmologist consultation with optional psychologist consultation

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Usual care groupActive comparator 1 intervention
Group B: Enhanced care groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Patient Satisfaction via PREM at 12 months

Difference in patient satisfaction via PREM (Patient Reported Experience Measure) at 12 months between the two arms. Items were rated on a 5-point Likert scale ranging from 1 (extremely worse than expected) to 5 (better than expected). Higher scores indicate a better perceived quality of care and psychological support.

Time frame
12 months

Secondary outcomes

1

Psychological impact after post-diagnostic support via HADS

Evaluation of the psychological impact of the enhanced post-diagnostic care. Longitudinal assessment of emotional well-being in the experimental group will be performed using the Hospital Anxiety and Depression Scale (HADS) at three key time points. Each subscale (anxiety and depression) ranges from 0 to 21, with higher scores indicating greater symptom severity (worse outcome).

Time frame
15 days, 6 months and 12 months after diagnosis
2

Feasibility and staff experience of implementing enhanced post-diagnostic support via RETEX and observation log

Nursing staff will complete a RETEX (Retour d'Expérience) questionnaire to assess the feasibility of the enhanced post-diagnostic care. The questionnaire evaluates challenges such as physician presence, adequacy of tools and setting, respect for patient privacy, communication with other staff, and consultation duration. The RETEX questionnaire consists of 11 dichotomous (Yes/No) items completed by nursing staff. Total score ranges from 0 to 11. Higher scores indicate greater perceived emotional and/or organizational burden, whereas lower scores indicate better feasibility and professional comfort.

Time frame
15 days, 6 months and 12 months after diagnosis

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.